| Net Cash Provided by (Used in) Operating Activities |
$2,720,000,000 |
USD |
-5.5% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,085,000,000 |
USD |
79% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$43,000,000 |
USD |
-102% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
12,000,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
2,805,961,317 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.3333 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,592,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$4,492,000,000 |
USD |
42% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$779,000,000 |
USD |
17% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,644,000,000 |
USD |
-8.8% |
Q4 2025 |
FY 2025 |
| Depreciation |
$134,000,000 |
USD |
-8.8% |
Q4 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$38,000,000 |
USD |
8.6% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$6,720,000,000 |
USD |
-42% |
Q4 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$4,672,000,000 |
USD |
3% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$26,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Unrecognized Tax Benefits |
$585,000,000 |
USD |
107% |
Q4 2025 |
FY 2025 |
| Amortization of Intangible Assets |
$132,000,000 |
USD |
-5% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$71,000,000 |
USD |
9.2% |
Q1 2025 |
Q1 2025 |